Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India. The company offers approximately 450 pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-parkinson, anti-depressant, and anti-coagulant applications, as well as in new chemical entities. It also provides preservatives, such as parabens and parabens formulations for use in cosmetics, animal food, and personal care industries; and specialty chemicals for use in cosmetics, dyes, polymers, and agrochemicals. In addition, the company exports its products to approximately 25 countries worldwide. Ami Organics Limited was founded in 2004 and is based in Surat, India. The ISIN of this stock is INE00FF01017.